Gland Pharma Limited (NSE:GLAND)
India · Delayed Price · Currency is INR 2,250.00
-63.00 (-2.72%)
May 29, 2026, 3:30 PM IST
Gland Pharma Stock Forecast
Stock Price Forecast
According to 13 analysts polled by S&P Global, Gland Pharma stock has a consensus rating of "Buy" and an average price target of ₹2,151. The average 1-year stock price forecast is 4.38% lower than the current stock price, while the lowest is ₹1,590 (-29.33%) and the highest is ₹2,600 (+15.56%).
Price Target: ₹2,151 (-4.38%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Gland Pharma stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Jan '26 | Feb '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 5 | 5 | 5 | 6 |
| Buy | 2 | 3 | 3 | 2 | 2 | 3 |
| Hold | 2 | 2 | 1 | 1 | 1 | 1 |
| Sell | 1 | 1 | 1 | 2 | 2 | 0 |
| Strong Sell | 3 | 3 | 3 | 3 | 3 | 3 |
| Total | 11 | 12 | 13 | 13 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Hold Maintains ₹2,080 | Hold | Maintains | ₹2,080 | -7.56% | May 19, 2026 |
| ICICI Securities | ICICI Securities | Buy Maintains ₹2,275 | Buy | Maintains | ₹2,275 | +1.11% | Jan 29, 2026 |
Unknown Analyst Axis Direct No rating | Axis Direct | Buy Maintains ₹2,170 | Buy | Maintains | ₹2,170 | -3.56% | Jan 29, 2026 |
Unknown Analyst Motilal Oswal No rating | Motilal Oswal | Buy Maintains ₹2,050 | Buy | Maintains | ₹2,050 | -8.89% | Jan 28, 2026 |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.